HOME >> BIOLOGY >> NEWS
Vanderbilt's John Oates wins clinical research award

John A. Oates Jr., M.D., Thomas F. Frist Sr. Professor of Medicine and professor of Pharmacology at Vanderbilt University Medical Center, received the Sixteenth Annual Award of Excellence in Clinical Research from the General Clinical Research Centers Program April 17.

The award acknowledges outstanding clinical research, supported by the National Center for Research Resources of the National Institutes of Health.

The $5,000 award and certificate was conferred during the General Clinical Research Centers Program Directors meeting in Chicago. At the meeting, Oates delivered a lecture titled "Investigation on the Contribution of Cyclooxygenases to Human Disease."

"Dr. Oates is a legend in Clinical Research. He put Vanderbilt's clinical research on the map, and I was personally excited to propose him for this award, and gratified that others recognized, as we do, his enormous contributions," said Alastair Wood, M.D., associate dean of external affairs at Vanderbilt.

"There are several important features or characteristics of Vanderbilt that nurtured the research that went on here -- the intent of Vanderbilt Pharmacology to include human pharmacology within the scope of the academic mission of the department," Oates said. "Their commitment to it has brought strong basic science to bear on our clinical research. For the investigation of human pharmacology, this has been an ideal setting."

Oates said the Vanderbilt General Clinical Research Center has been recognized as one of the leading GCRC's in the United States, and a great asset to the Medical School.

"The General Clinical Research Center has provided essential resources for our research, initially under the leadership of Elliot Newman, and more recently, David Robertson," Oates said.

"Recently NIH leadership has rediscovered the importance of patient-oriented research and has taken a number of helpful steps to support it," Robertson said. "As attention has focused on the na
'"/>

Contact: Clinton Colmenares
clinton.colmenares@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
19-Apr-2004


Page: 1 2

Related biology news :

1. Researchers at Vanderbilts Free-Electron Laser Center are developing new forms of laser surgery, improved X-ray technology, and better methods for protein identification
2. Matrisian named Vanderbilts first chair of cancer biology
3. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
4. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
5. Innovative ceramic-on-metal hip replacements to undergo clinical trials
6. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
7. Warren Pharmaceuticals publishes results of preclinical evaluation
8. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
9. Scientists characterize new breast tumor subtypes with poor clinical outcomes
10. Uncertainty in clinical tests raises health care costs
11. Germany starts clinical development of a new tuberculosis vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2018)... and CARDIFF, Wales (PRWEB) , ... August 30, ... ... Agency. Martha Sanchez, senior scientist, IBM Research. Jacklyn Novak, infrared materials engineer, LightPath ... Katherine Johnson, the NASA mathematician who just celebrated her 100th birthday. Today, they ...
(Date:8/29/2018)... , ... August 29, 2018 ... ... validates first non-invasive technology to identify specific chromosomal abnormalities using morphological assessment ... Ovation Fertility and Australia-based Life Whisperer suggests that artificial ...
(Date:8/23/2018)... (PRWEB) , ... August 21, 2018 , ... ... the genomes of diverse cell types and species for the robust functional interrogation ... tool for the development of T-cell based immunotherapies, the study of the autoimmunity, ...
Breaking Biology News(10 mins):
(Date:8/23/2018)... ... August 22, 2018 , ... Crucial Data Solutions, Inc. ... it the first fully-featured app for electronic data capture (EDC) and electronic participant ... constitute 99 percent of the market share for mobile devices worldwide; in turn, ...
(Date:8/21/2018)... ... August 21, 2018 , ... The Connecticut Technology Council (CTC) ... of the fastest growing technology companies in Connecticut. This year’s group of top-ranked companies ... October 3, at the Connecticut Convention Center in Hartford. A complete list of the ...
(Date:8/17/2018)... ... August 16, 2018 , ... Ambry Genetics Corporation (“Ambry”), a ... were published today in JAMA Oncology, identifying new and confirming known hereditary breast ... Every year hereditary breast cancer affects more than 20,000 women while hereditary ovarian ...
(Date:8/14/2018)... ... August 14, 2018 , ... Buprenorphine (BUP) is ... BUP is often prescribed as a sublingual co-formulation with the opioid antagonist naloxone ... participants will learn from a review of the pharmacokinetics of BUP, NBP, and ...
Breaking Biology Technology:
Cached News: